Bausch Health Companies Inc. Net Income (Loss) Available to Common Stockholders, Basic
Bausch Health Companies Inc. (BHC) reported Net Income (Loss) Available to Common Stockholders, Basic of -$153.00 million for the 3-month period ending 2020-12-31, per its 8-K filed 2021-05-04.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2021-05-04
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-12-31 was -$153.00M.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-09-30 was $71.00M.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-06-30 was -$326.00M.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-03-31 was -$152.00M.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for fiscal 2017 was $2.40B.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for fiscal 2016 was -$2.41B.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for fiscal 2014 was $881.00M.
- Bausch Health Companies Inc. net income (loss) available to common stockholders, basic for fiscal 2013 was -$866.10M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$153.00M 8-K · filed 2021-05-04 | -$82.00M derived: sum of 2 quarters · filed 2021-05-04 | -$408.00M derived: sum of 3 quarters · filed 2021-05-04 | -$560.00M 8-K · filed 2021-05-04 | ||||
| 2020-09-30 | $71.00M 8-K · filed 2021-05-04 | -$255.00M derived: sum of 2 quarters · filed 2021-05-04 | -$407.00M 10-Q · filed 2020-11-03 | -$1.92B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2020-06-30 | -$326.00M 8-K · filed 2021-05-04 | -$478.00M 10-Q · filed 2020-08-06 | -$1.99B derived: sum of 3 quarters · filed 2021-05-04 | -$2.04B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2020-03-31 | -$152.00M 8-K · filed 2021-05-04 | -$1.67B derived: sum of 2 quarters · filed 2021-05-04 | -$1.72B derived: sum of 3 quarters · filed 2021-05-04 | -$1.89B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-12-31 | -$1.52B 8-K · filed 2021-05-04 | -$1.56B derived: sum of 2 quarters · filed 2021-05-04 | -$1.74B derived: sum of 3 quarters · filed 2021-05-04 | -$1.79B 8-K · filed 2021-05-04 | ||||
| 2019-09-30 | -$49.00M 8-K · filed 2021-05-04 | -$220.00M derived: sum of 2 quarters · filed 2021-05-04 | -$272.00M 10-Q · filed 2020-11-03 | -$616.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | -$171.00M 8-K · filed 2021-05-04 | -$223.00M 10-Q · filed 2020-08-06 | -$567.00M derived: sum of 3 quarters · filed 2021-05-04 | -$917.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | -$52.00M 8-K · filed 2021-05-04 | -$396.00M derived: sum of 2 quarters · filed 2021-05-04 | -$746.00M derived: sum of 3 quarters · filed 2021-05-04 | -$1.62B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | -$344.00M 10-K · filed 2020-02-19 | -$694.00M derived: sum of 2 quarters · filed 2020-02-19 | -$1.57B derived: sum of 3 quarters · filed 2020-02-19 | -$4.15B 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | -$350.00M 10-K · filed 2020-02-19 | -$1.22B derived: sum of 2 quarters · filed 2020-02-19 | -$3.80B 10-Q · filed 2019-11-04 | -$3.29B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$873.00M 10-K · filed 2020-02-19 | -$3.45B 10-Q · filed 2019-08-06 | -$2.94B derived: sum of 3 quarters · filed 2020-02-19 | -$1.64B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$2.58B 10-K · filed 2020-02-19 | -$2.69B 10-Q · filed 2018-05-08 | -$2.07B derived: sum of 2 quarters · filed 2020-02-19 | -$767.00M derived: sum of 3 quarters · filed 2020-02-19 | -$805.00M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $513.00M 10-K · filed 2019-02-20 | $1.81B derived: sum of 2 quarters · filed 2019-02-20 | $1.78B derived: sum of 3 quarters · filed 2019-02-20 | $2.40B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $1.30B 10-K · filed 2019-02-20 | $1.26B derived: sum of 2 quarters · filed 2019-02-20 | $1.89B 10-Q · filed 2018-11-06 | $1.38B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$38.00M 10-K · filed 2019-02-20 | $590.00M 10-Q · filed 2018-08-07 | $75.00M derived: sum of 3 quarters · filed 2019-02-20 | -$1.14B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $628.00M 10-K · filed 2019-02-20 | $113.00M derived: sum of 2 quarters · filed 2019-02-20 | -$1.10B derived: sum of 3 quarters · filed 2019-02-20 | -$1.41B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$515.00M 8-K · filed 2018-08-10 | -$1.73B derived: sum of 2 quarters · filed 2018-08-10 | -$2.04B derived: sum of 3 quarters · filed 2018-08-10 | -$2.41B 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$1.22B 8-K · filed 2018-08-10 | -$1.22B 10-Q · filed 2016-11-09 | -$1.52B derived: sum of 2 quarters · filed 2018-08-10 | -$1.89B 10-Q · filed 2017-11-07 | -$1.89B 10-Q · filed 2016-11-09 | -$2.28B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | -$302.00M 8-K · filed 2018-08-10 | -$302.30M 10-Q · filed 2016-08-09 | -$676.00M 10-Q · filed 2017-08-08 | -$1.06B derived: sum of 3 quarters · filed 2018-08-10 | -$1.01B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | -$374.00M 8-K · filed 2018-08-10 | -$373.70M 10-Q · filed 2016-06-07 | -$759.00M derived: sum of 2 quarters · filed 2018-08-10 | -$710.00M derived: sum of 3 quarters · filed 2018-08-10 | -$763.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | -$385.00M 10-K · filed 2017-03-01 | -$385.90M 10-K · filed 2016-04-29 | -$336.00M derived: sum of 2 quarters · filed 2017-03-01 | -$389.00M derived: sum of 3 quarters · filed 2017-03-01 | -$292.00M 8-K · filed 2018-08-10 | -$291.70M 10-K · filed 2016-04-29 | ||
| 2015-09-30 | $49.00M 10-K · filed 2017-03-01 | $49.50M 10-Q · filed 2015-10-26 | -$4.00M derived: sum of 2 quarters · filed 2017-03-01 | $94.20M 10-Q · filed 2016-11-09 | $70.20M 10-Q · filed 2015-10-26 | $605.50M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | -$53.00M 10-K · filed 2017-03-01 | $44.70M 10-Q · filed 2016-08-09 | $20.70M 10-Q · filed 2015-07-28 | $556.50M derived: sum of 3 quarters · filed 2017-03-01 | $821.50M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $97.00M 10-K · filed 2017-03-01 | $73.70M 10-Q · filed 2015-04-30 | $609.50M derived: sum of 2 quarters · filed 2017-03-01 | $874.50M derived: sum of 3 quarters · filed 2017-03-01 | $1.00B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $512.50M 10-K · filed 2016-04-29 | $777.50M derived: sum of 2 quarters · filed 2016-04-29 | $903.30M derived: sum of 3 quarters · filed 2016-04-29 | $881.00M 10-K · filed 2017-03-01 | $913.50M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $265.00M 10-K · filed 2016-04-29 | $275.40M 10-Q · filed 2014-10-24 | $390.80M derived: sum of 2 quarters · filed 2016-04-29 | $368.20M 10-K · filed 2016-04-29 | $378.60M 10-Q · filed 2014-10-24 | $492.00M derived: sum of 4 quarters · filed 2016-04-29 | ||
| 2014-06-30 | $125.80M 10-K · filed 2016-04-29 | $103.20M 10-K · filed 2016-04-29 | $227.00M derived: sum of 3 quarters · filed 2016-04-29 | -$746.20M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | -$22.60M 10-K · filed 2016-04-29 | $101.20M derived: sum of 2 quarters · filed 2016-04-29 | -$872.00M derived: sum of 3 quarters · filed 2016-04-29 | -$861.20M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $123.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$849.40M derived: sum of 2 quarters · filed 2016-04-29 | -$838.60M derived: sum of 3 quarters · filed 2016-04-29 | -$866.10M 10-K · filed 2016-04-29 | -$866.14M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | -$973.20M 10-Q · filed 2014-10-24 | -$973.24M 10-Q · filed 2013-11-01 | -$962.40M derived: sum of 2 quarters · filed 2014-10-24 | -$989.90M 10-Q · filed 2014-10-24 | -$989.91M 10-Q · filed 2013-11-01 | -$1.08B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $10.80M 10-Q · filed 2014-08-01 | $10.87M 10-Q · filed 2013-08-07 | -$16.70M 10-Q · filed 2014-08-01 | -$16.66M 10-Q · filed 2013-08-07 | -$105.82M derived: sum of 3 quarters · filed 2015-02-25 | -$98.17M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | -$27.50M 10-Q · filed 2014-05-09 | -$27.53M 10-Q · filed 2013-05-03 | -$116.62M derived: sum of 2 quarters · filed 2015-02-25 | -$108.97M derived: sum of 3 quarters · filed 2015-02-25 | -$130.58M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | -$89.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$81.47M derived: sum of 2 quarters · filed 2015-02-25 | -$103.08M derived: sum of 3 quarters · filed 2015-02-25 | -$116.00M 10-K · filed 2015-02-25 | -$116.03M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $7.64M 10-Q · filed 2013-11-01 | -$13.96M derived: sum of 2 quarters · filed 2013-11-01 | -$26.88M 10-Q · filed 2013-11-01 | $28.97M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$21.61M 10-Q · filed 2013-08-07 | -$34.53M 10-Q · filed 2013-08-07 | $21.33M derived: sum of 3 quarters · filed 2014-02-28 | $62.19M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | -$12.92M 10-Q · filed 2013-05-03 | $42.93M derived: sum of 2 quarters · filed 2014-02-28 | $83.80M derived: sum of 3 quarters · filed 2014-02-28 | $140.16M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $55.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $96.72M derived: sum of 2 quarters · filed 2014-02-28 | $153.08M derived: sum of 3 quarters · filed 2014-02-28 | $159.56M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $40.86M 10-Q · filed 2012-11-05 | $97.22M derived: sum of 2 quarters · filed 2012-11-05 | $103.70M 10-Q · filed 2012-11-05 | $72.57M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $56.36M 10-Q · filed 2012-08-03 | $62.84M 10-Q · filed 2012-08-03 | $31.71M derived: sum of 3 quarters · filed 2013-02-28 | -$176.17M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $6.48M 10-Q · filed 2012-05-04 | -$24.65M derived: sum of 2 quarters · filed 2013-02-28 | -$232.53M derived: sum of 3 quarters · filed 2013-02-28 | |||||
| 2010-12-31 | -$31.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$239.01M derived: sum of 2 quarters · filed 2013-02-28 | -$208.19M 10-K · filed 2013-02-28 | |||||
| 2010-09-30 | -$207.88M 10-Q · filed 2011-11-04 | -$177.06M 10-Q · filed 2011-11-04 | ||||||
| 2009-12-31 | $176.46M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |